Selected research
Industry Research
Lisdexamfetamine API Industry Research Report 2026
Market perspective
The global Lisdexamfetamine API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lisdexamfetamine API is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lisdexamfetamine API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lisdexamfetamine API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lisdexamfetamine API include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lisdexamfetamine API market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Lisdexamfetamine API.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lisdexamfetamine API Market by Company
Yichang Humanwell Pharmaceutical
Sichuan Credit Chemwerth Pharmaceutical
Jiangsu Huataichenguang Pharmaceutical
China National Medicines Guorui Pharmaceutical
SynZeal Research
Fermion
Embio Limited
Benuvia
Lisdexamfetamine API Segment by Type
USP Grade
EP Grade
Other
Lisdexamfetamine API Segment by Application
Tablets
Oral Solution
Capsules
Lisdexamfetamine API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisdexamfetamine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lisdexamfetamine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisdexamfetamine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lisdexamfetamine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lisdexamfetamine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lisdexamfetamine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- USP Grade
- EP Grade
- Other
Applications
- Tablets
- Oral Solution
- Capsules
Companies covered
- Yichang Humanwell Pharmaceutical
- Sichuan Credit Chemwerth Pharmaceutical
- Jiangsu Huataichenguang Pharmaceutical
- China National Medicines Guorui Pharmaceutical
- SynZeal Research
- Fermion
- Embio Limited
- Benuvia
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Lisdexamfetamine API by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 USP Grade
- 2.2.3 EP Grade
- 2.2.4 Other
- 2.3 Lisdexamfetamine API by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Oral Solution
- 2.3.4 Capsules
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Lisdexamfetamine API Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Lisdexamfetamine API Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Lisdexamfetamine API Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Lisdexamfetamine API Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lisdexamfetamine API Production by Manufacturers (2021-2026)
- 3.2 Global Lisdexamfetamine API Production Value by Manufacturers (2021-2026)
- 3.3 Global Lisdexamfetamine API Average Price by Manufacturers (2021-2026)
- 3.4 Global Lisdexamfetamine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Lisdexamfetamine API Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Lisdexamfetamine API Manufacturers, Product Type & Application
- 3.7 Global Lisdexamfetamine API Manufacturers Established Date
- 3.8 Global Lisdexamfetamine API Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yichang Humanwell Pharmaceutical
- 4.1.1 Yichang Humanwell Pharmaceutical Lisdexamfetamine API Company Information
- 4.1.2 Yichang Humanwell Pharmaceutical Lisdexamfetamine API Business Overview
- 4.1.3 Yichang Humanwell Pharmaceutical Lisdexamfetamine API Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Yichang Humanwell Pharmaceutical Product Portfolio
- 4.1.5 Yichang Humanwell Pharmaceutical Recent Developments
- 4.2 Sichuan Credit Chemwerth Pharmaceutical
- 4.2.1 Sichuan Credit Chemwerth Pharmaceutical Lisdexamfetamine API Company Information
- 4.2.2 Sichuan Credit Chemwerth Pharmaceutical Lisdexamfetamine API Business Overview
- 4.2.3 Sichuan Credit Chemwerth Pharmaceutical Lisdexamfetamine API Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Sichuan Credit Chemwerth Pharmaceutical Product Portfolio
- 4.2.5 Sichuan Credit Chemwerth Pharmaceutical Recent Developments
- 4.3 Jiangsu Huataichenguang Pharmaceutical
- 4.3.1 Jiangsu Huataichenguang Pharmaceutical Lisdexamfetamine API Company Information
- 4.3.2 Jiangsu Huataichenguang Pharmaceutical Lisdexamfetamine API Business Overview
- 4.3.3 Jiangsu Huataichenguang Pharmaceutical Lisdexamfetamine API Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Jiangsu Huataichenguang Pharmaceutical Product Portfolio
- 4.3.5 Jiangsu Huataichenguang Pharmaceutical Recent Developments
- 4.4 China National Medicines Guorui Pharmaceutical
- 4.4.1 China National Medicines Guorui Pharmaceutical Lisdexamfetamine API Company Information
- 4.4.2 China National Medicines Guorui Pharmaceutical Lisdexamfetamine API Business Overview
- 4.4.3 China National Medicines Guorui Pharmaceutical Lisdexamfetamine API Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 China National Medicines Guorui Pharmaceutical Product Portfolio
- 4.4.5 China National Medicines Guorui Pharmaceutical Recent Developments
- 4.5 SynZeal Research
- 4.5.1 SynZeal Research Lisdexamfetamine API Company Information
- 4.5.2 SynZeal Research Lisdexamfetamine API Business Overview
- 4.5.3 SynZeal Research Lisdexamfetamine API Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 SynZeal Research Product Portfolio
- 4.5.5 SynZeal Research Recent Developments
- 4.6 Fermion
- 4.6.1 Fermion Lisdexamfetamine API Company Information
- 4.6.2 Fermion Lisdexamfetamine API Business Overview
- 4.6.3 Fermion Lisdexamfetamine API Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Fermion Product Portfolio
- 4.6.5 Fermion Recent Developments
- 4.7 Embio Limited
- 4.7.1 Embio Limited Lisdexamfetamine API Company Information
- 4.7.2 Embio Limited Lisdexamfetamine API Business Overview
- 4.7.3 Embio Limited Lisdexamfetamine API Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Embio Limited Product Portfolio
- 4.7.5 Embio Limited Recent Developments
- 4.8 Benuvia
- 4.8.1 Benuvia Lisdexamfetamine API Company Information
- 4.8.2 Benuvia Lisdexamfetamine API Business Overview
- 4.8.3 Benuvia Lisdexamfetamine API Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Benuvia Product Portfolio
- 4.8.5 Benuvia Recent Developments
5 Global Lisdexamfetamine API Production by Region
- 5.1 Global Lisdexamfetamine API Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lisdexamfetamine API Production by Region: 2021-2032
- 5.2.1 Global Lisdexamfetamine API Production by Region: 2021-2026
- 5.2.2 Global Lisdexamfetamine API Production Forecast by Region (2027-2032)
- 5.3 Global Lisdexamfetamine API Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Lisdexamfetamine API Production Value by Region: 2021-2032
- 5.4.1 Global Lisdexamfetamine API Production Value by Region: 2021-2026
- 5.4.2 Global Lisdexamfetamine API Production Value Forecast by Region (2027-2032)
- 5.5 Global Lisdexamfetamine API Market Price Analysis by Region (2021-2026)
- 5.6 Global Lisdexamfetamine API Production and Value, YOY Growth
- 5.6.1 North America Lisdexamfetamine API Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Lisdexamfetamine API Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Lisdexamfetamine API Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Lisdexamfetamine API Production Value Estimates and Forecasts (2021-2032)
6 Global Lisdexamfetamine API Consumption by Region
- 6.1 Global Lisdexamfetamine API Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Lisdexamfetamine API Consumption by Region (2021-2032)
- 6.2.1 Global Lisdexamfetamine API Consumption by Region: 2021-2026
- 6.2.2 Global Lisdexamfetamine API Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Lisdexamfetamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Lisdexamfetamine API Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Lisdexamfetamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Lisdexamfetamine API Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Lisdexamfetamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Lisdexamfetamine API Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Lisdexamfetamine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Lisdexamfetamine API Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Lisdexamfetamine API Production by Type (2021-2032)
- 7.1.1 Global Lisdexamfetamine API Production by Type (2021-2032) & (t)
- 7.1.2 Global Lisdexamfetamine API Production Market Share by Type (2021-2032)
- 7.2 Global Lisdexamfetamine API Production Value by Type (2021-2032)
- 7.2.1 Global Lisdexamfetamine API Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Lisdexamfetamine API Production Value Market Share by Type (2021-2032)
- 7.3 Global Lisdexamfetamine API Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Lisdexamfetamine API Production by Application (2021-2032)
- 8.1.1 Global Lisdexamfetamine API Production by Application (2021-2032) & (t)
- 8.1.2 Global Lisdexamfetamine API Production Market Share by Application (2021-2032)
- 8.2 Global Lisdexamfetamine API Production Value by Application (2021-2032)
- 8.2.1 Global Lisdexamfetamine API Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Lisdexamfetamine API Production Value Market Share by Application (2021-2032)
- 8.3 Global Lisdexamfetamine API Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Lisdexamfetamine API Value Chain Analysis
- 9.1.1 Lisdexamfetamine API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Lisdexamfetamine API Production Mode & Process
- 9.2 Lisdexamfetamine API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Lisdexamfetamine API Distributors
- 9.2.3 Lisdexamfetamine API Customers
10 Global Lisdexamfetamine API Analyzing Market Dynamics
- 10.1 Lisdexamfetamine API Industry Trends
- 10.2 Lisdexamfetamine API Industry Drivers
- 10.3 Lisdexamfetamine API Industry Opportunities and Challenges
- 10.4 Lisdexamfetamine API Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst